ArticleWorld journal of urology2025
The role of netrin-1 in the diagnosis and prognosis of bladder pain syndrome /interstitial cystitis: a comparative study.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeTo investigate the diagnostic and prognostic value of netrin-1 in Bladder Pain Syndrome /Interstitial Cystitis (BPS/IC).
methodsA total of 40 BPS/IC patients, 20 patients with overactive bladder (OAB), and 20 healthy controls were included. Baseline data of all participants were collected. Plasma netrin-1 expression levels were measured before treatment and two months after treatment. Statistical significance of differences among the three groups was analyzed. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic and prognostic value of netrin-1.
resultsThe netrin-1 expression level in the BPS/IC group was 777.37 ± 268.02 pg/ml, which was significantly higher than in the other two groups (P < 0.001). No significant difference in netrin-1 expression was observed between the OAB group and the healthy control group. Netrin-1 expression was positively correlated with ICSI, ICPI, and VAS scores. The netrin-1 expression level two months after treatment in the BPS/IC group was 485.06 ± 135.99 pg/ml, which was significantly lower than before treatment
conclusionNetrin-1 can serve as a diagnostic and prognostic biomarker for BPS/IC. However, the underlying mechanisms of netrin-1 in BPS/IC remain unclear and require further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.